Key Events This Week
18 May: New 52-week high at Rs.1,656.10
19 May: Fresh 52-week high at Rs.1,662.00 and MarketsMOJO upgrades rating to Buy
20 May: New 52-week high at Rs.1,679.45
22 May: Week closes at Rs.1,601.90 (-0.24%)

Broad-Based Technical Strength Lifts Ipca Laboratories Ltd to 52-Week High of Rs 1679.45
2026-05-20 10:37:20With a steady climb over the past five sessions delivering a near 10% gain, Ipca Laboratories Ltd surged to a fresh 52-week high of Rs 1679.45 on 20 Jun 2026, outpacing the broader market’s subdued performance and signalling robust price momentum.
Read full news article
Broad-Based Technical Strength Lifts Ipca Laboratories Ltd to 52-Week High of Rs 1662
2026-05-19 09:40:00With a steady four-day gain culminating in a 9.43% rise, Ipca Laboratories Ltd has surged to a fresh 52-week high of Rs 1662 on 19 Jun 2026, outperforming the Sensex which remains subdued below its 50-day moving average.
Read full news article
MarketsMOJO Upgrades Ipca Laboratories Ltd to Buy on Strong Technical and Financial Metrics
2026-05-19 08:38:33Ipca Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements in its technical indicators, valuation metrics, financial trends, and overall quality. The pharmaceutical company’s stock has demonstrated robust price momentum and solid fundamentals, prompting a reassessment of its investment appeal by MarketsMOJO analysts.
Read full news article
Broad-Based Technical Strength Lifts Ipca Laboratories Ltd to 52-Week High of Rs 1656.1
2026-05-18 13:35:13With a decisive break above Rs 1656.1 on 18 Jun 2026, Ipca Laboratories Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.
Read full news article
Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-05-18 08:02:42Ipca Laboratories Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by robust price action, positive signals from key technical indicators such as MACD and moving averages, and a strong relative performance against the Sensex over multiple timeframes.
Read full news article
Ipca Laboratories Ltd Valuation Shifts Amidst Market Outperformance
2026-05-18 08:02:22Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. Despite this, the stock has delivered robust returns over multiple time horizons, outperforming the Sensex significantly. This article analyses the recent valuation changes, compares Ipca Labs with its peers, and assesses the implications for investors amid evolving market dynamics.
Read full news articleIpca Laboratories Gains 3.48%: 3 Key Factors Driving the Week’s Rally
2026-05-16 14:04:17
Key Events This Week
May 11: Stock opens at Rs.1,533.30 amid downgrade to Hold
May 14: Intraday surge of 5.57% to Rs.1,590 signals strong rebound
May 15: New 52-week high of Rs.1,625 achieved
May 15: Week closes at Rs.1,605.75, outperforming Sensex

Broad-Based Technical Strength Lifts Ipca Laboratories Ltd to 52-Week High of Rs 1625
2026-05-15 09:43:01With a decisive surge to Rs 1625 on 15 Jun 2026, Ipca Laboratories Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to its sector and the broader market.
Read full news articleIPCA Laboratories Limited - Other General Purpose
27-Nov-2019 | Source : NSEIPCA Laboratories Limited has submitted to the Exchange a copy of Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
IPCA Laboratories Limited - Updates
26-Nov-2019 | Source : NSEIPCA Laboratories Limited has informed the Exchange regarding 'Update on US FDA'.
IPCA Laboratories Limited - Updates
04-Nov-2019 | Source : NSEIPCA Laboratories Limited has informed the Exchange regarding ' a Conference Call to discuss the Company's Q2 FY20 earnings and business update will be held on Friday, 8th November, 2019 at 11.00 hrs IST'.
Corporate Actions
29 May 2026
Ipca Laboratories Ltd has declared 200% dividend, ex-date: 05 Aug 25
Ipca Laboratories Ltd has announced 1:2 stock split, ex-date: 10 Jan 22
No Bonus history available
No Rights history available






